Bioprocess Technology Market, By Type (Flow Cytometry, Cell Expansion, Cell line Development, Virus Infiltration), By Application (Biopharmaceuticals, Specialty Products and Industrial Chemicals, Environmental Management aid), End-Users (Biotechnology & Biopharmaceutical Companies, Research & Academic Institutes, Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032

Bioprocess technology is an important part of biotechnology that deals with the process of combining all living matter or its components with nutrients to produce special chemicals, reagents and bio-therapeutics, these processes form the backbone of translating life science discoveries into useful industrial products. Bioprocess technology is the biological application involving living cells or their components to bring about the desired transformation of substrates. Bioprocesses are classified into two stages: preparation, production and purification, major advantages of bioprocesses over traditional chemical processes are that they require milder reaction conditions, are more specific and efficient, and produce renewable biomass, expanded by the development of recombinant DNA technology and enhanced bioprocess capacity. The most important applications of bioprocess-engineering research and development related to agriculture and food include the production of agrochemicals for animal and plant disease control, growth promoters for improved yields, and biological pesticides and herbicides; Enhancing bioprocesses And biotechnology is used in the production of medicines, foods, flavors, fuels and chemicals with the help of biocatalysts such as enzymes, microorganisms, plant or animal cells in bioreactors. Over the past few years, the use of bioprocess technology in the development of bio similar and biopharmaceutical products has fueled market growth and industry expansion, and increased investment through product innovation and enhanced creativity and potential, Investors are expected to drive the growth and process of the bioprocess technology market in the coming years.

The bioprocess technology market is primarily driven by the large adoption of this technology in industries such as food and beverages, pharmaceuticals, agriculture, and biotechnology And another rapid growth of the pharmaceutical industry, increasing spending on research and development activities in the biotechnology sector, increased demand for vaccines, ongoing technological advances, increasing number of new drug production and launches, and increasing incidence and prevalence of cancer and HIV. And product launches with emerging markets are expected to improve market growth in the coming year. Introducing advanced bioprocess products to tap untapped market opportunities will continue to be a key driver of growth in the coming years. However, stringent regulatory policies and high cost of bioprocess technology restrain the growth of this market. Various global governments are already reeling and some of them are opting for strict regulation policies related to market instruments with high price support which is preventing the market from growing during the forecast period.

Technological advancement

Continuous technological advancements in bioprocess, increasing support from governments of various countries for biofuel production are expected to drive growth of the bioprocess technology market. From cell biology and gene integration to bioprocess media and chromatographic technology, there have been major technological advances in various aspects of bio production. Manufacturers involved in the bioprocess technology market are developing advanced versions of their products due to new age technological advancements. Major bioprocess technology players are investing more in power systems and creating more modern, time-saving, cost-effective technologies that have a positive impact on the bioprocess technology market. In November 2022, researchers from the Chinese Academy of Sciences' Qingdao Institute of Bioenergy and Bioprocess Technology proposed a new technique called single-cell Raman-activated sorting and cultivation, or scRACS-culture, to detect cells in the environment through screening. Conservationists used the scRACS-Culture method to directly mine such cells from wastewater samples by observing their metabolic rate when only organic-phosphate substrates were available.

The Bioprocess Technology Market is segmented based on type, application, end-user and region.

Bioprocess Technology Market, By Type

On the basis of type, the Bioprocess Technology Market is segmented into Flow Cytometry, Cell Expansion, Cell line Development, Virus Infiltration. In Type,

Flow cytometry is a common method for rapid analysis of large numbers of cells using light-scattering, fluorescence, and absorbance measurements, a laser-based technique used to detect and catalyze the chemical and physical characteristics of cells or particles. Cell expansion requires synthesis of new cell wall material and controlled loosening to increase wall area. Immobilized cell lines are widely used in many important areas of biology (eg, recombinant protein and monoclonal antibody production), drug screening, and gene functional studies.

Bioprocess Technology Market, By Application

On the basis of application, the target market is classified into Biopharmaceuticals, Specialty Products and Industrial Chemicals, Environmental Management aid. Bioprocessing or biotechnology is used in the production of pharmaceuticals, foods, flavors, fuels and chemicals with the help of biocatalysts such as enzymes, microorganisms, plant cells or animal cells in bioreactors. An important application of environmental biotechnology is bio monitoring, biodegradability, toxicity, mutagenicity, concentration of hazardous substances and concentration and pathogenicity of microorganisms in waste and environment.

Bioprocess Technology Market, By End-User

On the basis of end-user, the target market is classified into Biotechnology & Biopharmaceutical Companies, Research & Academic Institutes, Others. Bioprocess technology plays a very important role in the field of pharmaceutical research and development, biotechnology is the science that links with the technology used in the pharmaceutical industry and is proving to be beneficial in genetic testing and manufacturing of vaccines, increasing the demand for vaccines and driving the drug development market.

Regional Insights:

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

On region the Bioprocess Technology Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds the largest share of the market in 2021 and is projected to grow during the forecast period. The Asia Pacific region is expected to witness the highest market growth during the forecast period.

Report Scope:

egments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Bioprocess Technology Market report based on type, application, and region:

Bioprocess Technology Market, By Type:

• Flow Cytometry
• Cell Expansion
• Cell Line Development
• Virus Infiltration

Bioprocess Technology Market, By Application:

•  Biopharmaceuticals
• Specialty Products and Industrial Chemicals
• Environmental Management Aid

Bioprocess Technology Market, By End-User:

• Biotechnology & Biopharmaceutical Companies
• Research & Academic Institutes
• Others

Bioprocess Technology Market, By Region:

• North America
  • Middle East & Africa
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East & Africa
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • U.S.
  • Canada

The key players operating the Bioprocess Technology Market includes,

1. MilliporeSigma is a technology company that develops, manufactures and distributes a variety of biochemical and organic chemicals, providing chemical products, kits and services used in scientific research, biotechnology, pharmaceutical development, disease diagnosis and pharmaceuticals, diagnostics and high technology manufacturing. , enables customers to leverage solutions to help deliver scientific.
2. Danaher Corporation, Danaher's innovative companies are developing leading-edge diagnostic tools, life-saving scientific research, and protecting our food and water supplies.
3. GE Healthcare is a leading global medical technology and life sciences company, providing a broad portfolio of products, solutions and services used to diagnose, treat and monitor patients. Development and manufacture of biopharmaceuticals.
4. Lonza-Pharma & Biotech is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. The company provides product development services to the pharmaceutical and biological industries, including custom manufacturing of biopharmaceuticals and discovery systems and services for the bioscience sector.
5. Thermo Fisher Scientific Inc. Dedicated to biological and medical diagnostics and research, it manufactures and distributes scientific and medical equipment laboratory equipment, software, reagents, consumables, chemicals and services.
6. Sartorius Stadim Biotech is a supplier of equipment and services to biopharmaceutical companies, offering integrated solutions including filtration, fermentation, fluid management, purification and cell cultivation, its key products include laboratory balances, OEM weighing cells, mass comparators, weighing sets, lab Water systems, pipettes, fermenters, moisture analyzers, filters, bioreactor shakers, virus purification kits and centrifuges, etc.
7. Asahi Kasei Medical Corporation is a holding company that, through its subsidiaries, sells a variety of products and services, the firm is organized into four divisions based on the product or service.
8. Solace Medical is an innovative provider of biomaterials, devices and services for the life sciences and medical technology industries.
9. Charles River Laboratories International, Inc. It is an American pharmaceutical company specializing in gene therapy services for various preclinical and clinical laboratory, pharmaceutical, medical device and biotechnology industries.
10. Solid Biotech GmBH is a dynamic company specializing in engineering, developing and manufacturing innovative bioprocess equipment, including bioreactors, fermenters, at-line analyzers, CIP/SIP systems and process vessels for research, development and production, fermentation, cell culture, suitable for stem cells, renewable technologies, algae, biomass, biofuels, hydrolysis and more.

Recent Developments:

• In November 2022, RVAC, a messenger RNA (mRNA) technology platform firm headquartered in Singapore, will work with research and development agency A*STAR to jointly establish the laboratory. The laboratory will be located at the A*STAR Bioprocessing Technology Institute in Singapore and will be used to develop a preclinical production platform, enabling the production of raw materials and potential clinical-grade assets for the development of mRNA vaccines and therapeutics.

• MilliporeSigma*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Danher Life Sciences
• GE Healthcare
• Lonza-Pharma & biotech
• Thermo Fisher Scientific
• Sartorius Stedim Biotech
• Asahi Kasei Medical
• Solesis Medical
• Charles River laboratories
• Solid Biotech GmBH.

 “*” marked represents similar segmentation in other categories in the respective section